Geographic Variation in Otolaryngologist Intranasal Steroid Prescribing Patterns Among Medicare Beneficiaries

被引:0
作者
Wu, Franklin M. [1 ]
Ulloa, Ruben [1 ]
Badash, Ido [2 ]
Hur, Kevin [2 ]
机构
[1] Univ Southern Calif, Keck Sch Med, 1450 San Pablo St,Suite 5708, Los Angeles, CA 90033 USA
[2] Univ Southern Calif, Caruso Dept Otolaryngol Head & Neck Surg, Keck Sch Med, Los Angeles, CA 90033 USA
关键词
intranasal corticosteroids; Medicare; healthcare costs; otolaryngologists; geographic variation; temperature correlation; FUROATE NASAL SPRAY; ALLERGIC RHINITIS; FLUTICASONE PROPIONATE; CORTICOSTEROIDS; PREFERENCES;
D O I
10.1177/00034894221079094
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: Intranasal corticosteroids (INCS) are a commonly prescribed medication to treat various rhinological conditions. However, no prior studies have looked at factors and patterns that influence the rates of INCS prescriptions among Medicare beneficiaries in the United States. Objective: This study aims to describe the patterns of INCS prescriptions by otolaryngologists for Medicare beneficiaries in the United States between 2013 and 2017. Methods: Data on the most common INCS prescriptions by otolaryngologists for Medicare beneficiaries were obtained from the 2013 to 2017 Medicare Provider Utilization and Payment Data: Physician and Other Supplier Public Use File (PUF) and the Part D Public Use Files from the Centers for Medicare and Medicaid Services (CMS). INCS prescriptions were analyzed by cost, state, provider, and regional temperature. State temperature data was collected through the National Centers for Environmental Information. Results: From 2013 to 2017, the total claims per beneficiary for fluticasone, mometasone, and triamcinolone combined increased from 2.31 to 2.39. Combined cost/beneficiary was similar for mometasone and triamcinolone at 102.47 and 103.60 respectively, while it was much lower for fluticasone at 39.12. There was a strong correlation between otolaryngology providers per beneficiary in each state and total claims per state with a correlation coefficient of .79. Additionally, comparing the average state temperature to the claims/beneficiary yielded a moderately strong correlation coefficient of .44, suggesting that temperature was a possible factor for INCS prescription patterns. Conclusions: INCS prescriptions by otolaryngologists and the number of INCS beneficiaries have increased between 2013 and 2017. Over the same time period, the costs of fluticasone and triamcinolone have decreased while the cost of mometasone increased. Total providers by state correlated with claims per state. Additionally, average annual temperature was positively correlated with INCS claims per beneficiary in each state.
引用
收藏
页码:126 / 132
页数:7
相关论文
共 24 条
  • [11] Assessing the cold temperature effect on hospital visit by allergic rhinitis in Seoul, Korea
    Kim, Hyomi
    Kim, Honghyok
    Lee, Jong-Tae
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2018, 633 : 938 - 945
  • [12] Seasonality of allergic diseases: Real-world evidence from a nationwide population-based study
    Lee, Young Chan
    Ju, Hyun Jeong
    Kwon, Jin-woo
    Bae, Jung Min
    [J]. IMMUNITY INFLAMMATION AND DISEASE, 2020, 8 (03) : 360 - 362
  • [13] A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis
    Lumry, WR
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (04) : S150 - S158
  • [14] Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis: A white paper
    Luskin, Allan T.
    Blaiss, Michael S.
    Farrar, Judith R.
    Settipane, Russell
    Hayden, Mary Lou
    Stoloff, Stuart
    Chadwick, Stephen J.
    Derebery, M. Jennifer
    Ettari, Mary P.
    Luskin, Susan
    Naclerio, Robert
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2011, 32 (02) : 168 - 177
  • [15] Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis
    Mandl, M
    Nolop, K
    Lutsky, BN
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1997, 79 (04) : 370 - 378
  • [16] Epidemiology of allergic rhinitis
    Mims, James W.
    [J]. INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2014, 4 : S18 - S20
  • [17] National Centers for Environmental Information, 2022, CLIM GLANC STAT MAPP
  • [18] Sanofi, 2013, FDA APPR SAN NAS ALL
  • [19] Sheikh A., 2007, BMJ CLIN EVID, V2007, P0509
  • [20] Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis
    Stokes, M
    Amorosi, SL
    Thompson, D
    Dupclay, L
    Garcia, J
    Georges, G
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2004, 131 (03) : 225 - 231